Christian Kanstrup
Fortuna: 65 619 $ al 31/05/2026
Fortuna: 65 619 $ al 31/05/2026
Christian Kanstrup is currently Chief Executive Officer at CKC ApS and Mr. Kanstrup Holding ApS, Chairman at Mediq Holding Danmark ApS, Independent Director at NNIT A since 2018, Director at Novo Nordisk Haemophilia Foundation, and Independent Director at Sleep Cycle AB starting in 2025.
Former roles include Chief Executive Officer at Evaxion AS from 2023 to 2025, Director at FastPassCorp A in 2019, Director at Glycom A, and SVP-Strategy, Access & Marketing at Novo Nordisk A from 2016 to 2017.
Education includes graduate degrees from the University of Copenhagen and the International Institute for Management Development.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
SLEEP CYCLE AB 0,09 % | 12/03/2026 | 17.500 ( 0,09 % ) | 46 530 $ | 31/05/2026 |
NNIT A/S 0,01 % | 31/12/2025 | 3.000 ( 0,01 % ) | 19 089 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| NNIT A/S | Director/Miembro de la Junta | 08/03/2018 |
| SLEEP CYCLE AB | Director/Miembro de la Junta | 28/10/2025 |
Novo Nordisk Haemophilia Foundation | Director/Miembro de la Junta | - |
Mediq Holding Danmark ApS
Mediq Holding Danmark ApS Financial ConglomeratesFinance Functions as an investment holding company | Presidente | - |
Christian Kanstrup Holding ApS | Director Ejecutivo | - |
CKC ApS | Director Ejecutivo | - |
| Empresas | Cargo | Fin |
|---|---|---|
| EVAXION A/S | Director Ejecutivo | 01/07/2025 |
| FASTPASSCORP A/S | Director/Miembro de la Junta | 02/03/2019 |
Glycom A/S
Glycom A/S BiotechnologyHealth Technology Engages in the development, synthesis, and commercialization of human milk oligosaccharides | Director/Miembro de la Junta | - |
| ░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 12 |
|---|---|
Novo Nordisk A/S
Novo Nordisk A/S Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products for diabetes care | Health Technology |
FastPassCorp A/S
FastPassCorp A/S Information Technology ServicesTechnology Services Provides password management solutions, account unlock, and mapping services | Technology Services |
University of Copenhagen
University of Copenhagen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
International Institute for Management Development
International Institute for Management Development Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Glycom A/S
Glycom A/S BiotechnologyHealth Technology Engages in the development, synthesis, and commercialization of human milk oligosaccharides | Health Technology |
NNIT A/S
NNIT A/S Information Technology ServicesTechnology Services Provides digital transformation solutions to international life sciences companies | Technology Services |
Novo Nordisk Haemophilia Foundation | |
Evaxion Biotech A/S
Evaxion Biotech A/S BiotechnologyHealth Technology Develops novel vaccines | Health Technology |
CKC ApS | |
Christian Kanstrup Holding ApS | |
Sleep Cycle AB
Sleep Cycle AB Packaged SoftwareTechnology Services Develops sleep applications and tools for tracking and analyzing sleep habits | Technology Services |
Mediq Holding Danmark ApS
Mediq Holding Danmark ApS Financial ConglomeratesFinance Functions as an investment holding company | Finance |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.